On July 4, President Donald Trump signed into law “The One Big Beautiful Bill Act,” which is expected to deal a massive blow to Medicaid coverage and leave millions without insurance by instituting a work requirement for beneficiaries.
Monica L. Baskin joined VCU Massey Comprehensive Cancer Center as deputy director of research.
Officials from VCU Massey Comprehensive Cancer Center awarded the center’s first $50,000 harvest grant to the Free Clinic of Powhatan, extending a commitment to the clinic’s “Eat Well, Be Well,” pilot nutrition program.
Kim F. Rhoads was named associate director of community outreach and engagement at VCU Massey Comprehensive Cancer Center.
The Robert A. Winn Clinical Investigator Pathway Program, a national program administered by VCU Massey Comprehensive Cancer Center, officially launched its fourth annual cohort.
As the Trump administration reshapes the cancer research enterprise that was built on the foundation of the National Cancer Act of 1971, the Cancer History Project presents an eyewitness account of the impact of this landmark law.
Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States. Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma... […]
Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, research suggests, which could contribute to higher rates of aggressive prostate cancer in African American men.
New research out of VCU Massey Comprehensive Cancer Center—published this month in Drug Resistance Updates—revealed a previously unknown biological process through which breast tumor cells develop resistance to standard treatment. It could open the door for cancer scientists to further target this vulnerability and create more effective therapies for disease.
Anthony Faber, a professor in the Philips Institute for Oral Health Research at the Virginia Commonwealth University School of Dentistry and Massey Comprehensive Cancer Center, has received four grants totaling more than $6.3 million to aid in the development of new targeted therapies for neuroblastoma and synovial sarcoma.
